Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-d-aspartate receptors
Authors:
- 1 September 2009
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 17 (17) , 6463-6480
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-d-aspartate ReceptorsMolecular Pharmacology, 2009
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive DisorderJournal of Clinical Psychopharmacology, 2008
- Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor AntagonistsJournal of Medicinal Chemistry, 2008
- Homology Modeling of NR2B Modulatory Domain of NMDA Receptor and Analysis of Ifenprodil BindingChemMedChem, 2007
- MemantineDrugs, 2006
- Expression and characterization of soluble amino‐terminal domain of NR2B subunit of N‐methyl‐d‐aspartate receptorProtein Science, 2005
- Glutamate Receptor GatingCritical Reviews™ in Neurobiology, 2004
- Toward Wisdom From FailureStroke, 2002
- State‐dependent NMDA receptor antagonism by Ro 8‐4304, a novel NR2B selective, non‐competitive, voltage‐independent antagonistBritish Journal of Pharmacology, 1998
- The novel N-Methyl-D-Aspartate (NMDA) antagonist CGS 19755 prevents ischemia-induced reductions of adenosine A1, NMDA, and PCP receptors in gerbil brainSynapse, 1988